FSSAI Initiates Legal Action Against Nestle India Over Infant Nutrition Products
The Food Safety and Standards Authority of India (FSSAI) has initiated three adjudication cases against Nestle India concerning alleged non-compliance with regulations on infant nutrition products. The cases involve promotional claims on NAN Excella Pro Stage 1 and Lactogen Pro 1, which were found to violate rules restricting advertising of infant foods. Additionally, a follow-up formula was found sub-standard in biotin content after laboratory tests. Nestle India's shares declined by around 2-3% following the announcement.
First-hand measurement across 13 sources
We measured how 13 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (41/100). Lens Score 48/100.
Outlets measured: deccanherald, businessstandard, businessstandard, news18, mint, indiatoday, thetelegraph, news18, and 5 more. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment ranged widely across outlets — from 32/100 to 62/100 — a sign the coverage itself was contested, not just reported.
Coverage timeline
economictimes broke this story on 18 Sept, 06:46 am. Other outlets followed.
